English  |  正體中文  |  简体中文  |  2856565  
???header.visitor??? :  53424129    ???header.onlineuser??? :  634
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yang c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 371-380 of 1273  (128 Page(s) Totally)
<< < 33 34 35 36 37 38 39 40 41 42 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-01T02:02:21Z Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract Hsu C.; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:21Z Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:18Z Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T02:02:18Z Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏 2021-09-01T02:02:17Z Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein Yang C.-H.; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG; Whang-Peng J.; Yang P.-C.
臺大學術典藏 2021-09-01T02:02:15Z Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏 2021-09-01T02:02:09Z Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; ANN-LII CHENG; Lee Y.-C.
臺大學術典藏 2021-09-01T02:02:08Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Lin C.-C.; ANN-LII CHENG; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏 2021-09-01T02:02:07Z Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial Lin C.-C.; Hsu C.; Hsu C.-H.; Hsu W.-L.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-09-01T02:02:06Z A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma Chen Y.-M.; Yu C.-J.; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; ANN-LII CHENG; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C.

Showing items 371-380 of 1273  (128 Page(s) Totally)
<< < 33 34 35 36 37 38 39 40 41 42 > >>
View [10|25|50] records per page